Steadybase.

SS Innovations International, Inc.

Website Investor relations LinkedIn Latest 10-K
  • SSII · Nasdaq
  • Surgical & Medical Instruments & Apparatus
  • Gurugram, India
  • 483 employees
  • CIK 0001676163

Updated from SEC filings through

Top things to know

Executives

SS Innovations International, Inc. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Gurugram, India. It trades as SSII on Nasdaq. Revenue was $42.5M in the fiscal year ending December 31, 2025, +105.7% from the year before. It reported about 483 employees. Srivastava Sudhir is Chairman and CEO.

Five-year financials

MetricFY2025FY2024FY2023FY2022FY2021
Revenue $42.5M
10-K, 2026-03-10
$20.6M
10-K, 2026-03-10
$5.9M
10-K, 2025-04-15
$1.4M
10-K/A, 2024-12-20
Not on file
Operating income -$8.2M
10-K, 2026-03-10
-$19.0M
10-K, 2026-03-10
-$20.3M
10-K, 2025-04-15
-$3.0M
10-K/A, 2024-12-20
Not on file
SG&A $14.8M
10-K, 2026-03-10
$10.2M
10-K, 2026-03-10
$10.1M
10-K, 2025-04-15
$1.9M
10-K/A, 2024-12-20
$459K
10-K, 2023-03-31
Net income -$12.1M
10-K, 2026-03-10
-$19.2M
10-K, 2026-03-10
-$20.9M
10-K, 2025-04-15
-$3.2M
10-K/A, 2024-12-20
-$1.5M
10-K, 2023-03-31

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Srivastava Sudhir Chairman and CEO 4, 2026-09-09
Pascual Srivastava Vishwajyoti CEO - Asia Pacific 4, 2026-06-04
Sarah Romano CFO 3, 2026-08-04
Milan Rao Global Chief Operating Officer and Chief Financial Officer 10-K, 2026-03-10
Barry F. Cohen Barry F. Cohen COO - Americas 4, 2026-06-02
Mylswamy Annadurai Director 10-K, 2026-03-10
Tim Adams Director 10-K, 2026-03-10

What SS Innovations International, Inc. does

We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries.

Item 1. Business, 10-K for the year ending December 31, 2025

Shares and governance

Shares outstanding 200.4 million (as of August 12, 2026) 10-Q, August 13, 2026
Public float $270M (as of June 30, 2025) 10-K/A, March 31, 2026
Reportable segments 1 (period ending June 30, 2026) 10-Q, August 13, 2026
Auditor BDO India Services Private Limited (Gurugram, India) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
September 4, 2026 Srivastava Sudhir
Chairman and CEO
Sale 33,333 $100K Form 4, September 9, 2026
March 6, 2026 Frederic H. Moll
Director
Buy 501,253 $2.0M Form 4, March 10, 2026
March 6, 2026 Timothy P. Adams
Director
Buy 300,000 $1.2M Form 4, March 10, 2026
March 6, 2026 Srivastava Sudhir
Chairman and CEO
Buy 498,753 $2.0M Form 4, March 10, 2026

Recent 8-K events

Frequently asked questions about SS Innovations International, Inc.

What does SS Innovations International, Inc. do?
In its own words, from Item 1 of its 10-K: "We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries."
What is SS Innovations International, Inc.'s revenue?
$42.5M for the fiscal year ending December 31, 2025, from its 10-K filed March 10, 2026.
Is SS Innovations International, Inc. profitable?
SS Innovations International, Inc. reported net income of -$12.1M for the fiscal year ending December 31, 2025.
How many employees does SS Innovations International, Inc. have?
About 483 as of December 31, 2025, as stated in its annual report.
Who is the CEO of SS Innovations International, Inc.?
Srivastava Sudhir, Chairman and CEO, as named in a 4 filed September 9, 2026.
Who is the CFO of SS Innovations International, Inc.?
Sarah Romano, CFO, as named in a 3 filed August 4, 2026.
Where is SS Innovations International, Inc. headquartered?
Gurugram, India.
What is SS Innovations International, Inc.'s stock ticker?
SSII on Nasdaq.
What industry is SS Innovations International, Inc. in?
Surgical & Medical Instruments & Apparatus, SIC code 3841.
What is SS Innovations International, Inc.'s website?
ssinnovations.com. Investor relations: https://ssinnovations.com/investors_v2/.
When does SS Innovations International, Inc. report earnings next?
November 10, 2026. Source: pg_future_events.
Is SS Innovations International, Inc. a public company?
Yes. SS Innovations International, Inc. files with the SEC under CIK 0001676163 and trades as SSII.
Who audits SS Innovations International, Inc.?
BDO India Services Private Limited, Gurugram, India, as named in its latest annual report (10-K).
How many shares of SS Innovations International, Inc. are outstanding?
200.4 million shares as of August 12, 2026, from its 10-Q filed August 13, 2026.
What is SS Innovations International, Inc.'s public float?
$270M as of June 30, 2025, as reported on the cover of its 10-K/A filed March 31, 2026.
How many business segments does SS Innovations International, Inc. report?
1 reportable segment for the period ending June 30, 2026, from its 10-Q filed August 13, 2026.
Have SS Innovations International, Inc. insiders traded stock recently?
Since March 6, 2026, officers and directors reported 1 open-market sale worth about $100K and 3 purchases worth about $5.2M on Forms 4 and 5. The most recent: Srivastava Sudhir (Chairman and CEO) sold 33,333 shares on September 4, 2026.